Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) fell 4.6% to $0.7055 on volume of 174,330,167 shares PROSHARES TRUST (SQQQ) rose 2.3% to $11.92 on volume of 147,409,535 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.0% to $4.61 on volume ...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) fell 4.3% to $0.707999 on volume of 163,563,003 shares PROSHARES TRUST (SQQQ) rose 2.9% to $11.9857 on volume of 127,669,453 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.2% to $4.62 on vol...
ATLANTA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether RAPT Therapeutics, Inc. (“RAPT Therapeutics,” or the “Company”) (NASDAQ: RAPT) complied with federal securities laws. On February 20, 2024, the Company “ann...
2024-02-20 12:50:54 ET Gainers: Pop Culture Group Co Ltd ( CPOP ) +176% . AgriFORCE Growing Systems ltd ( AGRI ) +95% . Trxade Health ( MEDS ) +92% . Intuitive Machines ( LUNR ) +48% . Iovance Biotherapeutics ( IOVA ) +39% . ...
2024-02-20 10:22:31 ET More on RAPT Therapeutics RAPT Therapeutics: Positive Data, But I Think They're Overvalued For Now Evercore ISI starts RAPT at outperform, cites upcoming Phase 2b data Seeking Alpha’s Quant Rating on RAPT Therapeutics Historical ...
2024-02-20 10:00:11 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Healthcare dealmakers see inc...
- RAPT to host a conference call today at 8:30 am ET - SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecu...
2024-02-16 13:41:12 ET More on RAPT Therapeutics RAPT Therapeutics: Positive Data, But I Think They're Overvalued For Now Seeking Alpha’s Quant Rating on RAPT Therapeutics Historical earnings data for RAPT Therapeutics Financial information for RAPT Th...
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamma...
2024-02-06 12:30:27 ET Summary RAPT is working mainly on inhibitors of CCR4 to treat eczema, asthma, and cancers. Although there are promising findings being generated by their studies, we need more follow up and more power to draw firm conclusions. The overall outlook cannot ...
News, Short Squeeze, Breakout and More Instantly...
RAPT Therapeutics Inc. Company Name:
RAPT Stock Symbol:
NYSE Market:
RAPT Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
2024-02-23 01:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...